Embo-Ibouanga, A.W.; Nguyen, M.; Paloque, L.; Coustets, M.; Joly, J.-P.; Augereau, J.-M.; Vanthuyne, N.; Bikanga, R.; Coquin, N.; Robert, A.;
et al. Hybrid Peptide-Alkoxyamine Drugs: A Strategy for the Development of a New Family of Antiplasmodial Drugs. Molecules 2024, 29, 1397.
https://doi.org/10.3390/molecules29061397
AMA Style
Embo-Ibouanga AW, Nguyen M, Paloque L, Coustets M, Joly J-P, Augereau J-M, Vanthuyne N, Bikanga R, Coquin N, Robert A,
et al. Hybrid Peptide-Alkoxyamine Drugs: A Strategy for the Development of a New Family of Antiplasmodial Drugs. Molecules. 2024; 29(6):1397.
https://doi.org/10.3390/molecules29061397
Chicago/Turabian Style
Embo-Ibouanga, Ange W., Michel Nguyen, Lucie Paloque, Mathilde Coustets, Jean-Patrick Joly, Jean-Michel Augereau, Nicolas Vanthuyne, Raphaël Bikanga, Naomie Coquin, Anne Robert,
and et al. 2024. "Hybrid Peptide-Alkoxyamine Drugs: A Strategy for the Development of a New Family of Antiplasmodial Drugs" Molecules 29, no. 6: 1397.
https://doi.org/10.3390/molecules29061397
APA Style
Embo-Ibouanga, A. W., Nguyen, M., Paloque, L., Coustets, M., Joly, J.-P., Augereau, J.-M., Vanthuyne, N., Bikanga, R., Coquin, N., Robert, A., Audran, G., Boissier, J., Mellet, P., Benoit-Vical, F., & Marque, S. R. A.
(2024). Hybrid Peptide-Alkoxyamine Drugs: A Strategy for the Development of a New Family of Antiplasmodial Drugs. Molecules, 29(6), 1397.
https://doi.org/10.3390/molecules29061397
